Learn more about the newly awarded T32 and the six graduate students it will fund.
Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.
We have been awarded a five-year $1.5 million grant to fund graduate student training in clinical and translational research from the National Center for Advancing Translational Sciences!
Learn more about the newly awarded T32 and the six graduate students it will fund.
Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.